147 related articles for article (PubMed ID: 11197264)
1. Can postoperative relapse of Crohn's disease be prevented?
Dumois RA; Herrera JL
Am J Gastroenterol; 2001 Jan; 96(1):249. PubMed ID: 11197264
[No Abstract] [Full Text] [Related]
2. [Crohn's disease surgery: problems of postoperative recurrence].
Fornaro R; Frascio M; Stabilini C; Sticchi C; Barberis A; Denegri A; Ricci B; Azzinnaro A; Lazzara F; Gianetta E
Chir Ital; 2008; 60(6):761-81. PubMed ID: 19256268
[TBL] [Abstract][Full Text] [Related]
3. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Prantera C; Bellinvia S
Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
[No Abstract] [Full Text] [Related]
4. [Mesalazine for maintenance of medically-induced remission in Crohn disease: a survey of a Cochrane review].
Thomsen OØ; Nielsen OH
Ugeskr Laeger; 2005 Aug; 167(33):3015-7. PubMed ID: 16109240
[No Abstract] [Full Text] [Related]
5. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
6. [Maintaining a remission].
Fleig WE;
Z Gastroenterol; 2003 Jan; 41(1):36-42. PubMed ID: 12541172
[No Abstract] [Full Text] [Related]
7. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
8. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
9. Prevention of postoperative recurrence in Crohn's disease.
Terdiman JP
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):616-20. PubMed ID: 17967564
[No Abstract] [Full Text] [Related]
10. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
Glintborg B
Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
[TBL] [Abstract][Full Text] [Related]
11. [Mesalazine is without clinical effect in patients with Crohn disease].
Munck LK
Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804
[No Abstract] [Full Text] [Related]
12. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
13. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
14. Drug prophylaxis of recurrence of Crohn's disease after resection: the way to go.
Rutgeerts P
Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):231. PubMed ID: 9675665
[No Abstract] [Full Text] [Related]
15. [A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].
Hedin A; Ehrsson H; Eksborg S; Finkel Y; Hildebrand H; Lidehäll AK
Lakartidningen; 2001 Oct; 98(40):4343-6. PubMed ID: 11685756
[No Abstract] [Full Text] [Related]
16. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
Bresci G; Parisi G; Capria A
Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420
[TBL] [Abstract][Full Text] [Related]
17. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Hanauer SB; Korelitz BI; Rutgeerts P; Peppercorn MA; Thisted RA; Cohen RD; Present DH
Gastroenterology; 2004 Sep; 127(3):723-9. PubMed ID: 15362027
[TBL] [Abstract][Full Text] [Related]
18. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
Neĭman KP; Rumiantsev VG
Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
[No Abstract] [Full Text] [Related]
19. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
20. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Ardizzone S; Maconi G; Sampietro GM; Russo A; Radice E; Colombo E; Imbesi V; Molteni M; Danelli PG; Taschieri AM; Bianchi Porro G
Gastroenterology; 2004 Sep; 127(3):730-40. PubMed ID: 15362028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
